ConductScience.org, home

Paper39411684

Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization.

Liao R and 11 others. Bioact Mater, 2025. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization. Papers, record 39411684. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39411684

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization.
PubMed
Journal
Bioact Mater
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
7.05, provisional
iCite
Revised in PubMed
2024-10-18
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liao RRan
2Sun ZCZhi-Chao
3Wang LLiying
4Xian CCaihong
5Lin RRan
6Zhuo GGuifeng
7Wang HHaiyan
8Fang YYifei
9Liu YYuntao
10Yang RRongyuan
11Wu JJun
12Zhang ZZhongde

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129466596Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment.JAMA2018https://conductscience.org/library/papers/29466596PubMed
236037505Hybrid Biomimetic Nanovesicles to Drive High Lung Biodistribution and Prevent Cytokine Storm for ARDS Treatment.ACS Nano2022https://conductscience.org/library/papers/36037505PubMed
336069260Spatiotemporally Targeted Polypeptide Nanoantidotes Improve Chemotherapy Tolerance of Cisplatin.Angew Chem Int Ed Engl2022https://conductscience.org/library/papers/36069260PubMed
433547233Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/33547233PubMed
521761867Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant.ACS Nano2011https://conductscience.org/library/papers/21761867PubMed
632863203Targeting NOX4 alleviates sepsis-induced acute lung injury via attenuation of redox-sensitive activation of CaMKII/ERK1/2/MLCK and endothelial cell barrier dysfunction.Redox Biol2020https://conductscience.org/library/papers/32863203PubMed
730872586Acute respiratory distress syndrome.Nat Rev Dis Primers2019https://conductscience.org/library/papers/30872586PubMed
833945618COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria.Blood2021https://conductscience.org/library/papers/33945618PubMed
938590795Edaravone-loaded poly(amino acid) nanogel inhibits ferroptosis for neuroprotection in cerebral ischemia injury.Asian J Pharm Sci2024https://conductscience.org/library/papers/38590795PubMed
1039091384Brain-Targeted Drug Delivery Platforms for Ischemic Stroke Therapy.BME Front2024https://conductscience.org/library/papers/39091384PubMed
1133977080Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design.Acta Pharm Sin B2021https://conductscience.org/library/papers/33977080PubMed
1234311538Natural molecule Munronoid I attenuates LPS-induced acute lung injury by promoting the K48-linked ubiquitination and degradation of TAK1.Biomed Pharmacother2021https://conductscience.org/library/papers/34311538PubMed
1334366849Glycoproteins From Rabdosia japonica var. glaucocalyx Regulate Macrophage Polarization and Alleviate Lipopolysaccharide-Induced Acute Lung Injury in Mice via TLR4/NF-κB Pathway.Front Pharmacol2021https://conductscience.org/library/papers/34366849PubMed
1424039257Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction.Am J Physiol Lung Cell Mol Physiol2013https://conductscience.org/library/papers/24039257PubMed
1536583377Interactions of Inhaled Liposome with Macrophages and Neutrophils Determine Particle Biofate and Anti-Inflammatory Effect in Acute Lung Inflammation.ACS Appl Mater Interfaces2023https://conductscience.org/library/papers/36583377PubMed
1622975080Altered lung function relates to inflammation in an acute LPS mouse model.Pulm Pharmacol Ther2012https://conductscience.org/library/papers/22975080PubMed
1735346768The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs.J Control Release2022https://conductscience.org/library/papers/35346768PubMed
1837849509Nanoantidotes: A Detoxification System More Applicable to Clinical Practice.BME Front2023https://conductscience.org/library/papers/37849509PubMed
1930078618Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.Lancet Respir Med2018https://conductscience.org/library/papers/30078618PubMed
2033007416Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.Pharmacol Res2021https://conductscience.org/library/papers/33007416PubMed

See all 52 referencesDownload CSV of references

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42985531Inhaled Nanomedicines for Lung Diseases and Injuries: Pharmacological Advances and Clinical Translation.MedComm (2020)2026https://conductscience.org/library/papers/42985531PubMed
42761950Nanomedicine for Acute Respiratory Distress Syndrome: From Pathophysiological Mechanisms and Disease Heterogeneity to Precision Therapy.Int J Nanomedicine2026https://conductscience.org/library/papers/42761950PubMed
42654124Bergapten as a Multifunctional Phytochemical in Cancer Therapy: Mechanistic Insights, Pharmacokinetics, and Possible Nanotechnology-Enabled Formulation Strategies.Pharmaceutics2026https://conductscience.org/library/papers/42654124PubMed
42388220Advanced Multiscale Inhalation Platforms for Treatment of Pulmonary Diseases.Int J Nanomedicine2026https://conductscience.org/library/papers/42388220PubMed
42338572Small intracellular vesicle-liposome fusogenic nanoplatform sIVs-LPs@Hes: Nebulized delivery targeting pulmonary inflammatory microenvironment to improve ALI.Mater Today Bio2026https://conductscience.org/library/papers/42338572PubMed
42293730A safe and anti-inflammatory plant-derived nanovesicle platform for targeted delivery in acute lung injury.Bioact Mater2026https://conductscience.org/library/papers/42293730PubMed
42292702Bergapten attenuates oxidative stress and neuroinflammation to promote the survival and neuronal differentiation of neural stem/progenitor cells after ischemic insult.Biochem Biophys Rep2026https://conductscience.org/library/papers/42292702PubMed
42253924Acute Lung Injury: From Molecular Circuits to System-Level Therapeutics.MedComm (2020)2026https://conductscience.org/library/papers/42253924PubMed
42213091An Inhalable Apoptosis-Mimicking Functionalized Carbon Dots-Methylprednisolone Nanomedicine for Synergistic Therapy in Acute Lung Injury.Small2026https://conductscience.org/library/papers/42213091PubMed
41969646Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery.Bioact Mater2026https://conductscience.org/library/papers/41969646PubMed
41909672Selective JAK2 inhibition by TG101209 reprograms macrophage polarization and alleviates acute lung injury.Front Immunol2026https://conductscience.org/library/papers/41909672PubMed
41884518Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia-reperfusion lung injury and pneumonia.Bioact Mater2026https://conductscience.org/library/papers/41884518PubMed
41782990Hyaluronic acid engineered melanin-MOF nanoreactor synergistically remodeling redox and immune homeostasis for targeted acute lung injury therapy.Mater Today Bio2026https://conductscience.org/library/papers/41782990PubMed
41686220IFIT3 stabilizes STING via USP18 to drive M1 macrophage polarization and early inflammation in acute lung injury.Cell Mol Life Sci2026https://conductscience.org/library/papers/41686220PubMed
41677655Engineered CCR2 Cell Membrane-Wrapped Cepharanthine Liposomes for Potential Targeted Attenuation of Acute Lung Injury.Cells2026https://conductscience.org/library/papers/41677655PubMed
41647999Liposomes as carriers for garlic oil delivery to increase anti-inflammatory and antioxidant activities in mice with ALI.Exp Biol Med (Maywood)2026https://conductscience.org/library/papers/41647999PubMed
41613243Low-concentration cholesterol modification enhances Clematis filamentosa Dunn-derived extracellular vesicle-mediated macrophage polarization regulation for acute lung injury therapy.RSC Adv2026https://conductscience.org/library/papers/41613243PubMed
41584355Inhalable songorine-integrated lipid nanomedicine for targeted ARDS therapy via repairing endothelial barrier and inactivating NLRP3 inflammasome.Acta Pharm Sin B2026https://conductscience.org/library/papers/41584355PubMed
41574664Advances in the mechanisms of the NLRP3 inflammasome in sepsis‑induced cardiomyopathy and targeted therapeutic studies (Review).Mol Med Rep2026https://conductscience.org/library/papers/41574664PubMed
41465505A Narrative Review on the Antitumoral Effects of Selected Mediterranean Plant Products from Southern Italy.Int J Mol Sci2025https://conductscience.org/library/papers/41465505PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39411684

GET https://conductscience.org/api/papers/v1/39411684/references?page=2